Literature DB >> 9681479

Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism.

S M Hutson1, D Berkich, P Drown, B Xu, M Aschner, K F LaNoue.   

Abstract

Because it is well known that excess branched-chain amino acids (BCAAs) have a profound influence on neurological function, studies were conducted to determine the impact of BCAAs on neuronal and astrocytic metabolism and on trafficking between neurons and astrocytes. The first step in the metabolism of BCAAs is transamination with alpha-ketoglutarate to form the branched-chain alpha-keto acids (BCKAs). The brain is unique in that it expresses two separate branched-chain aminotransferase (BCAT) isoenzymes. One is the common peripheral form [mitochondrial (BCATm)], and the other [cytosolic (BCATc)] is unique to cerebral tissue, placenta, and ovaries. Therefore, attempts were made to define the isoenzymes' spatial distribution and whether they might play separate metabolic roles. Studies were conducted on primary rat brain cell cultures enriched in either astroglia or neurons. The data show that over time BCATm becomes the predominant isoenzyme in astrocyte cultures and that BCATc is prominent in early neuronal cultures. The data also show that gabapentin, a structural analogue of leucine with anticonvulsant properties, is a competitive inhibitor of BCATc but that it does not inhibit BCATm. Metabolic studies indicated that BCAAs promote the efflux of glutamine from astrocytes and that gabapentin can replace leucine as an exchange substrate. Studying astrocyte-enriched cultures in the presence of [U-14C]glutamate we found that BCKAs, but not BCAAs, stimulate glutamate transamination to alpha-ketoglutarate and thus irreversible decarboxylation of glutamate to pyruvate and lactate, thereby promoting glutamate oxidative breakdown. Oxidation of glutamate appeared to be largely dependent on the presence of an alpha-keto acid acceptor for transamination in astrocyte cultures and independent of astrocytic glutamate dehydrogenase activity. The data are discussed in terms of a putative BCAA/BCKA shuttle, where BCATs and BCAAs provide the amino group for glutamate synthesis from alpha-ketoglutarate via BCATm in astrocytes and thereby promote glutamine transfer to neurons, whereas BCATc reaminates the amino acids in neurons for another cycle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681479     DOI: 10.1046/j.1471-4159.1998.71020863.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  New Horizons in the development of antiepileptic drugs: Innovative strategies.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsy Res       Date:  2006-06       Impact factor: 3.045

2.  Phenylbutyrate therapy for maple syrup urine disease.

Authors:  Nicola Brunetti-Pierri; Brendan Lanpher; Ayelet Erez; Elitsa A Ananieva; Mohammad Islam; Juan C Marini; Qin Sun; Chunli Yu; Madhuri Hegde; Jun Li; R Max Wynn; David T Chuang; Susan Hutson; Brendan Lee
Journal:  Hum Mol Genet       Date:  2010-11-23       Impact factor: 6.150

3.  Docking and quantitative structure-activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase.

Authors:  Julio Caballero; Ariela Vergara-Jaque; Michael Fernández; Deysma Coll
Journal:  Mol Divers       Date:  2009-04-07       Impact factor: 2.943

4.  Effects of Branched-Chain Amino Acid Supplementation on Spontaneous Seizures and Neuronal Viability in a Model of Mesial Temporal Lobe Epilepsy.

Authors:  Shaun E Gruenbaum; Roni Dhaher; Amedeo Rapuano; Hitten P Zaveri; Amber Tang; Nihal de Lanerolle; Tore Eid
Journal:  J Neurosurg Anesthesiol       Date:  2019-04       Impact factor: 3.956

5.  Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.

Authors:  Elitsa A Ananieva; Chirag H Patel; Charles H Drake; Jonathan D Powell; Susan M Hutson
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

Review 6.  Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Authors:  Cory Toth
Journal:  Ther Adv Drug Saf       Date:  2014-02

Review 7.  Carboxylation and anaplerosis in neurons and glia.

Authors:  B Hassel
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

8.  Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.

Authors:  Zhimin Gu; Yuxuan Liu; Feng Cai; McKenzie Patrick; Jakub Zmajkovic; Hui Cao; Yuannyu Zhang; Alpaslan Tasdogan; Mingyi Chen; Le Qi; Xin Liu; Kailong Li; Junhua Lyu; Kathryn E Dickerson; Weina Chen; Min Ni; Matthew E Merritt; Sean J Morrison; Radek C Skoda; Ralph J DeBerardinis; Jian Xu
Journal:  Cancer Discov       Date:  2019-06-12       Impact factor: 39.397

Review 9.  Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS.

Authors:  Marc Yudkoff
Journal:  Neurochem Res       Date:  2016-10-01       Impact factor: 3.996

10.  Biochemical correlates of neuropsychiatric illness in maple syrup urine disease.

Authors:  Emilie R Muelly; Gregory J Moore; Scott C Bunce; Julie Mack; Don C Bigler; D Holmes Morton; Kevin A Strauss
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.